Singapore, June 16 -- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co.(USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MoU).

The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, advancing localized oncology diagnostics.

The collaboration will leverage USKBio's existing infrastructure, and Gene Solutions' advanced next-generation AI & genomics capabilities to jointly establish anext-generation sequencing (NGS) laboratory. The lab will focus on accelerating access toearly cancer detectionandmolecular residual disease (MRD...